Literature DB >> 9952424

Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

M J LaVoie1, T G Hastings.   

Abstract

Methamphetamine-induced toxicity has been shown to require striatal dopamine and to involve mechanisms associated with oxidative stress. Dopamine is a reactive molecule that can oxidize to form free radicals and reactive quinones. Although this has been suggested to contribute to the mechanism of toxicity, the oxidation of dopamine has never been directly measured after methamphetamine exposure. In this study we sought to determine whether methamphetamine-induced toxicity is associated with the oxidation of dopamine by measuring the binding of dopamine quinones to cysteinyl residues on protein. We observed that administration of neurotoxic doses of methamphetamine to rats resulted in a two- to threefold increase in protein cysteinyl-dopamine in the striatum 2, 4, and 8 hr after treatment. When methamphetamine was administered at an ambient temperature of 5 degreesC, no increase in dopamine oxidation products was observed, and toxicity was prevented. Furthermore, as shown by striatal microdialysis, animals treated with methamphetamine at 5 degreesC showed DA release identical to that of animals treated at room temperature. These data suggest that the toxicity of methamphetamine and the associated increase in dopamine oxidation are not exclusively the result of increases in extracellular dopamine. Because dopamine-induced modifications of protein structure and function may result in cellular toxicity, it is likely that dopamine oxidation contributes to methamphetamine-induced toxicity to dopamine terminals, adding support to the role of dopamine and the evidence of oxidative stress in this lesion model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952424      PMCID: PMC6786023     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

1.  Catecholamine toxicity in cerebral cortex in dissociated cell culture.

Authors:  P A Rosenberg
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

2.  An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.

Authors:  B Fornstedt; I Bergh; E Rosengren; A Carlsson
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

3.  Liver hyperthermia and oxidative stress: role of iron and aldehyde production.

Authors:  J L Skibba; E A Gwartney
Journal:  Int J Hyperthermia       Date:  1997 Mar-Apr       Impact factor: 3.914

4.  Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

Authors:  S B Berman; M J Zigmond; T G Hastings
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

5.  Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration.

Authors:  A E Fleckenstein; D G Wilkins; J W Gibb; G R Hanson
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

6.  NMDA-dependent superoxide production and neurotoxicity.

Authors:  M Lafon-Cazal; S Pietri; M Culcasi; J Bockaert
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

7.  Conjugation of dopa and 5-S-cysteinyldopa with cysteine mediated by superoxide radical.

Authors:  S Ito; K Fujita
Journal:  Biochem Pharmacol       Date:  1982-09-15       Impact factor: 5.858

8.  Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

Authors:  J F Cubells; S Rayport; G Rajendran; D Sulzer
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

9.  Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.

Authors:  T Abekawa; T Ohmori; T Koyama
Journal:  Brain Res       Date:  1994-04-18       Impact factor: 3.252

10.  Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.

Authors:  D B Miller; J P O'Callaghan
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

View more
  141 in total

1.  Angiotensin receptor II is present in dopaminergic cell line of rat substantia nigra and it is down regulated by aminochrome.

Authors:  A Dagnino-Subiabre; K Marcelain; C Arriagada; I Paris; P Caviedes; R Caviedes; J Segura-Aguilar
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses.

Authors:  C Scheller; G Arendt; T Nolting; C Antke; S Sopper; M Maschke; M Obermann; A Angerer; I W Husstedt; F Meisner; E Neuen-Jacob; H W Müller; P Carey; V Ter Meulen; P Riederer; E Koutsilieri
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

3.  Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress.

Authors:  Lonnie Schneider; Samantha Giordano; Blake R Zelickson; Michelle S Johnson; Gloria A Benavides; Xiaosen Ouyang; Naomi Fineberg; Victor M Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2011-09-01       Impact factor: 7.376

4.  The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

Authors:  David M Thomas; Mariana Angoa Pérez; Dina M Francescutti-Verbeem; Mrudang M Shah; Donald M Kuhn
Journal:  J Neurochem       Date:  2010-09-06       Impact factor: 5.372

5.  Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.

Authors:  Pei-Wen Chu; Gregory C Hadlock; Paula Vieira-Brock; Kristen Stout; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2010-08-25       Impact factor: 5.372

6.  Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis.

Authors:  Ferogh A Ahmadi; Tom N Grammatopoulos; Andy M Poczobutt; Susan M Jones; Laurence D Snell; Mita Das; W Michael Zawada
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

Review 7.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

8.  Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.

Authors:  Florence F Roussotte; Boris A Gutman; Derrek P Hibar; Sarah K Madsen; Katherine L Narr; Paul M Thompson
Journal:  Alzheimers Dement       Date:  2014-12-10       Impact factor: 21.566

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

10.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.